BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34555519)

  • 21. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US.
    Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ
    Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
    Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
    J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
    Bräu N; Fox RK; Xiao P; Marks K; Naqvi Z; Taylor LE; Trikha A; Sherman M; Sulkowski MS; Dieterich DT; Rigsby MO; Wright TL; Hernandez MD; Jain MK; Khatri GK; Sterling RK; Bonacini M; Martyn CA; Aytaman A; Llovet JM; Brown ST; Bini EJ;
    J Hepatol; 2007 Oct; 47(4):527-37. PubMed ID: 17692986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
    Liu PH; Hsu CY; Su CW; Huang YH; Hou MC; Rich NE; Fujiwara N; Hoshida Y; Singal AG; Huo TI
    Liver Int; 2020 Oct; 40(10):2522-2534. PubMed ID: 32511831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
    Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Waterworth DM; Kendrick S; Sattar N; Alazawi W
    BMC Med; 2019 May; 17(1):95. PubMed ID: 31104631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact.
    Govalan R; Luu M; Lauzon M; Kosari K; Ahn JC; Rich NE; Nissen N; Roberts LR; Singal AG; Yang JD
    Hepatol Commun; 2022 Jan; 6(1):223-236. PubMed ID: 34558830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors of survival in patients with non-resectable hepatocellular carcinoma: hepatitis C versus miscellaneous etiology.
    Abbas Z; Siddiqui AU; Luck NH; Hassan M; Mirza R; Naqvi A; Rizvi AH
    J Pak Med Assoc; 2008 Nov; 58(11):602-7. PubMed ID: 19024130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching.
    Wu Z; Tang H; Wang L; Jin X; Lei Z; Yang P; Zhou J
    BMC Surg; 2022 Mar; 22(1):103. PubMed ID: 35313836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
    Costentin CE; Mourad A; Lahmek P; Causse X; Pariente A; Hagège H; Dobrin AS; Becker C; Marks B; Bader R; Condat B; Héluwaert F; Seitz JF; Lesgourgues B; Denis J; Deuffic-Burban S; Rosa I; Decaens T;
    Cancer; 2018 May; 124(9):1964-1972. PubMed ID: 29589878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of patients with hepatitis B virus-related acute on chronic liver failure: An observational cohort study.
    Lin S; Zhang K; Zhang J; Wang M; Velani B; Zhu Y
    Liver Int; 2019 May; 39(5):854-860. PubMed ID: 30753752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis.
    Vidal RIO; Vidal EIO; Pereira BB; Assane CC; Ribeiro A; do Nascimento EM; Romeiro FG; Ribeiro Filho J
    Biomed Res Int; 2020; 2020():1487593. PubMed ID: 33134370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Hsu PY; Hsu CT; Yeh ML; Huang CF; Huang CI; Liang PC; Lin YH; Hsieh MY; Wei YJ; Hsieh MH; Dai CY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Dig Dis Sci; 2020 Jul; 65(7):2120-2129. PubMed ID: 31722058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and survival of hepatocellular carcinoma in north-east Peninsular Malaysia.
    Norsa'adah B; Nurhazalini-Zayani CG
    Asian Pac J Cancer Prev; 2013; 14(11):6955-9. PubMed ID: 24377632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
    Zhang XX; Wang LF; Jin L; Li YY; Hao SL; Shi YC; Zeng QL; Li ZW; Zhang Z; Lau GK; Wang FS
    World J Gastroenterol; 2015 Mar; 21(12):3554-63. PubMed ID: 25834320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy.
    Goh MJ; Kang W; Jeong WK; Sinn DH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Sci Rep; 2022 May; 12(1):7647. PubMed ID: 35538112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance Rate and its Impact on Survival of Hepatocellular Carcinoma Patients in South Korea: A Cohort Study.
    Im S; Jang ES; Lee JH; Lee CS; Kim BH; Chung JW; Kim JW; Jeong SH
    Cancer Res Treat; 2019 Oct; 51(4):1357-1369. PubMed ID: 30744319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
    Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
    World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
    Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
    Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.